Intestinal form of acute radiation sickness clinic. Acute radiation sickness

In the clinical picture of radiation sickness, the individual sensitivity of the body to the reaction is of great importance; however, the damage mainly depends on the dose intensity and the area of the irradiated area.

Depending on the radiation dose, there are 4 degrees of radiation sickness in people who have undergone timely and rational treatment:

I. (mild) degree - 1-2 Gy

II. (average) degree - 2-4 Gy.

III. (severe) degree - 4-6 Gy

IV. (extremely severe) degree - 6-10 Gy

In recent years, it has been proposed to distinguish the most acute or fulminant forms of ARS with intestinal (10-20 Gy), toxic (20-80 Gy) and cerebral (80 Gy and above) variants of the course.

There are 4 periods of radiation sickness

I. Primary reaction period . It begins immediately after irradiation, and the more intense the radiation exposure, the sooner the reaction occurs. Characteristic of this period is an excited or depressed state, headache, dizziness, nausea, vomiting, in severe cases it is indomitable. Diarrhea is always mixed with blood.

Due to increased vascular permeability, there is hyperemia of the skin and slight swelling of the subcutaneous tissue, and in case of severe damage, the skin becomes pale due to the development of collapse, and loss of consciousness may occur. On the part of the nervous system, meningeal phenomena are noted: slight stiffness of the neck, p. Kernig, pathological reflexes of Babinsky, Rossolimo, Gordon, general hyperesthesia of the skin. Lethargy, drowsiness, adynamia, hand tremors, sweating of extremities, chills.

Thus, in the initial period of radiation sickness, functional reactions of overexcitation predominate. The duration of the first period is from several hours to 2-3 days. It should be noted the early development of lymphopenia already on the first day after irradiation, which is an early diagnostic sign.

II period (period of imaginary well-being). The patients' complaints decrease, their state of health becomes satisfactory, and lability of pulse, blood pressure, malaise, and asthenia may persist. The disease progresses, which can be traced by changes in the peripheral blood; leukocytosis gradually gives way to leukopenia by 5-7 days with the development of neutropenia, and anemia occurs. The duration of the second period is from several days to 2-4 weeks, but in severe cases it can be completely absent and the first period directly passes into the third.

III period - the period of peak of pronounced clinical phenomena.

It develops depending on the degree of damage after 1-3 weeks from the onset of the disease, in the most severe cases immediately after the initial periods. The main clinical picture of the disease is revealed, the features of the general toxic effect of radiation on the body, nervous system and hematopoiesis are determined. During this period, disorders of the central nervous system intensify, headaches that are difficult to treat, sleep disturbances, dizziness, nausea, and vomiting recur. A decrease in reflexes begins to be clearly visible. There may be hemorrhages in various parts of the brain. The skin is dry, flaky, and in severe cases, erythema appears with the formation of blisters, followed by disintegration and the development of gangrene. Baldness is a common symptom. Epilation begins in the second or third week after the lesion. Characteristic is the addition of a secondary infection, which occurs as a result of the immune defenselessness of the body due to a sharp disruption of hematopoiesis; the development of sepsis is possible.

Fever almost always occurs, necrotizing tonsillitis, gingivitis, and stomatitis often develop. Necrosis can occur in the intestinal mucosa, which causes abdominal pain and bloody diarrhea. During this period, the inhibition of hematopoiesis progresses, general weakness and hemorrhagic phenomena increase, the permeability of the vascular walls is impaired, and the amount of prothrombin decreases. Hemorrhagic syndrome manifests itself in the form of skin rashes and hemorrhages of various sizes and shapes, as well as in the form of bleeding (gastric, intestinal, pulmonary, nasal). Symptoms of damage to the cardiovascular system, primarily the myocardium (tachycardia, hypotension, shortness of breath, expansion of the borders of the heart, systolic murmur at the apex, ECG changes), impaired liver and kidney function, may develop. Tissue breakdown reaches a high degree, which manifests itself in a negative nitrogen balance.

The endocrine glands are also subject to changes, especially the gonads, pituitary gland and adrenal glands (hypofunction).

Changes occurring in the gonads lead to sterility. The trophism is significantly disrupted. The third period lasts 2-4 weeks, after which, if the course is favorable, it moves into the 4th period.

Radiation sickness - a kind of general disease that develops as a result of the damaging effects of ionizing radiation on the body .

Distinguish acute and chronic radiation sickness.

The modern classification of acute radiation sickness is based on the experimentally and clinically firmly established dependence of the severity and form of damage on the received radiation dose.

Acute radiation sickness- a nosological form that develops during external gamma and gamma neutron irradiation in a dose exceeding 1 gray (Gy) (1 Gy = 100 rad), received simultaneously or over a short period of time (from 3 to 10 days), as well as when ingestion of radionuclides creating an adequate absorbed dose.

The primary effect of radiation is realized in physical, physicochemical and chemical processes with the formation of chemically active free radicals (H+, OH-, water) with high oxidative and reducing properties. Subsequently, various peroxide compounds (hydrogen peroxide, etc.) are formed. Oxidizing radicals and peroxides inhibit the activity of some enzymes and increase others. As a result, secondary radiobiological effects occur at various levels of biological integration.

Of primary importance in the development of radiation injuries are disturbances in the physiological regeneration of cells and tissues, as well as changes in the function of regulatory systems. Great sensitivity to the action of ionizing radiation of hematopoietic tissue, intestinal and skin epithelium, and spermatogenic epithelium has been proven. Muscle and bone tissue are less radiosensitive. High radiosensitivity in physiological terms, but relatively low radiosusceptibility in anatomical terms, are characteristic of the nervous system.

Various clinical forms of ARS are characterized by certain leading pathogenetic mechanisms of the formation of the pathological process and corresponding clinical syndromes.

By severity differentiate four degreesacute radiation sickness :

I - light (radiation dose 1-2 Gy)

II - moderate severity (irradiation dose 2-4 Gy);

Ш - heavy (radiation dose 4-6 Gy);

IV - extremely severe (radiation dose over 6 Gy).

Acute radiation sickness, stage I characterized by mild clinical manifestations.

· The initial reaction may include one-time vomiting, moderate weakness, mild headache and leukocytosis.

· The latent period lasts up to 5 weeks.

· During the peak period, deterioration in well-being and moderate changes in the blood system (the number of leukocytes decreases to 3-10 9 / l) and the activity of other physiological systems are observed.

· Usually, by the end of the 2nd month, patients experience complete restoration of combat and working capacity.

For acute radiation sickness II degree periods of illness are clearly expressed, but severe general condition is not observed in those affected.

· The initial reaction lasts up to 1 day. Nausea and 2 or 3 times vomiting, general weakness, and low-grade body temperature occur.

· Latent period 3-4 weeks.

· At the height of the disease, the level of leukocytes decreases only to 1.8-0.8 -10 9 /l. Baldness is pronounced, hemorrhagic manifestations are moderate (skin petechiae, nosebleeds are possible).

· There are no necrotic changes in the pharynx and gastrointestinal tract.

· Severe infectious complications are rare.

· In half of the cases, after 2-3 months, combat and working capacity is completely restored.

Acute radiation sickness III degree is difficult.

· Violent primary reaction 30-60 minutes after irradiation, lasting up to 2 days, nausea, repeated vomiting, general weakness, low-grade body temperature, headache.

· The development of dyspeptic syndrome already in the first tens of minutes and the early appearance of diarrhea indicate exposure to radiation at a dose of more than 6 Gy.

· The latent period is 10-15 days, but weakness remains.

· Hair falls out early.

· Lymphocytopenia and thrombocytopenia rapidly increase, the number of leukocytes sharply decreases (to 0.5-10 9 /l and below), agranulocytosis develops, sometimes severe anemia,

· Multiple hemorrhages, necrotic changes, infectious complications and sepsis appear.

· The prognosis is serious, but not hopeless.

Acute radiation sickness IV degree:

· The initial reaction, from the moment of irradiation, proceeds extremely violently, lasts 3-4 days, is accompanied by uncontrollable vomiting and severe weakness, reaching adynamia.

· Possible general skin erythema, loose stools, collapse, psychomotor disorder, early hematopoietic disorder.

· The prognosis is unfavorable.

In the most acute, “fulminant” form (radiation dose 10-100 Gy), death occurs within 1-3 to 8-12 days.

With increasing dose and radiation power, the clinical manifestations of the disease intensify. With uneven exposure to radiation, the most severe forms of the disease develop after irradiation of the abdominal organs.

Depending on the possible manifestations there are bone marrow, intestinal, toxic and cerebral forms of ARS .

Bone marrow form – a typical form of ARS, occurs frequently, develops with irradiation at a dose of 1-10 Gray. The leading symptom in the clinical picture of the disease is impaired hematopoiesis.

The course of the bone marrow form of radiation sickness is characterized by a certain cyclicity and wave-like nature, in connection with which the following are distinguished: four periods , which are especially typical in moderate and severe cases:

· general primary reaction ;

· latent, or relative clinical well-being ;

· the height of , or pronounced clinical manifestations;

· recovery .

Period of general primary reaction begins immediately or several hours after irradiation. Typically, the earlier signs of the primary reaction appear and the longer it lasts, the more severe the radiation sickness.

Main symptoms of the primary reaction:

Nausea and vomiting (multiple in severe cases),

general weakness, headache and dizziness.

· slight psychomotor agitation that appears at first is soon replaced by mental depression and lethargy.

· Patients are often bothered by thirst and dry mouth.

Body temperature is usually normal or moderately elevated.

· there are signs of instability of the autonomic nervous system (tachycardia, fluctuations in blood pressure, hyperhidrosis, hyperemia and some puffiness of the facial skin).

· in the most severe cases (superlethal radiation), shortness of breath, diarrhea, severe cerebral symptoms up to loss of consciousness, complete prostration, convulsions and a shock-like state are observed.

· the primary reaction is characterized by neutrophilic leukocytosis (10-20-10 9 /l) with a shift to the left, as well as a mild decrease in the number of lymphocytes. Leukocytosis can give way to leukopenia after a few hours.

· shifts are observed in various types of metabolism.

· the primary reaction lasts from several hours to 2 days, then its manifestations subside and the second period begins.

Latent period (hidden), or relative clinical well-being , is characterized mainly by:

· improvement of well-being,

· disappearance of some painful manifestations of the primary reaction (nausea and vomiting, headache).

· However, changes in the blood are clearly expressed: Leukopenia increases (up to 3-1.5-10 9 /l), it becomes persistent, thrombocytopenia gradually increases, reticulocytes almost completely disappear from the peripheral blood, and red blood cells undergo degenerative changes.

· Hypoplasia begins to develop in the bone marrow - a sign of suppressed hematopoiesis.

· Qualitatively changed cells appear in the peripheral blood: hypersegmentation of neutrophil nuclei, their toxic granularity, anisocytosis, poikilocytosis, etc.

· The depth of lymphocytopenia on the 3-4th day of illness is of greatest importance for diagnosis and prognosis.

· The latent period usually lasts 2-4 weeks; in mild forms - up to 5 weeks, in extremely severe forms it may be absent. The more severe the lesion, the shorter the latent period, and vice versa.

High period, or pronounced clinical manifestations :

The timing of the peak period and its duration depend on the severity of ARS:

· 1 tbsp. occurs on the 30th day, lasts 10 days;

· 2 tbsp. occurs on the 20th, lasts 15 days;

· 3 tbsp. occurs on the 10th, lasts 30 days;

· 4 tbsp. occurs in 4–8 days, and death occurs in 3–6 weeks.

· The clinical transition from the latent to the peak period occurs abruptly (excluding mild degrees), begins with a deterioration in health and is characterized by a polymorphic clinical picture.

· General weakness increases, appetite disappears, body temperature rises and, depending on the severity of the disease, it ranges from low-grade to hectic.

· Trophic phenomena develop: hair falls out, the skin becomes dry and flaky; Swelling sometimes appears on the face, hands and feet.

· Characterized by the development of hemorrhagic syndrome (subcutaneous hemorrhages, nasal, gastric and uterine bleeding), ulcerative-necrotic changes (stomatitis, conjunctivitis), infectious complications (bronchitis, pneumonia, cystitis, pyelitis). In severe cases, abdominal pain and diarrhea may appear.

· Sometimes the disease occurs as sepsis.

· At the height of the disease, the depression of the blood system reaches a particularly sharp degree. First of all, the leukocyte count decreases (to 2-1-10 9 /l), sometimes agranulocytosis develops (the number of leukocytes is below 1-10 9 /l), and anemia increases. All this is a consequence of suppression or almost complete cessation of bone marrow hematopoiesis.

· Changes in the blood coagulation system are pronounced, which contributes to the development of hemorrhagic syndrome, the main factor of which is thrombocytopenia (below 5-10 10 /l).

· The peak period lasts 2-4 weeks.

Recovery period Depending on the severity of the disease, it lasts from one to several months.

· Usually the transition to recovery occurs gradually. Signs of asthenia, vegetative-vascular instability and functional disorders in the activity of a number of organs and physiological systems of the body (gastrointestinal dyskinesia, chronic gastritis, enterocolitis, certain disorders in the blood system) persist for a long time.

· One of the first objective signs of the onset of the recovery period is appearance of reticulocytes in the blood. Sometimes their number reaches 70 per 1000 red blood cells, which is considered as a kind of reticulocyte crisis.

· An increase in the number of monocytes and eosinophils in the blood can be noted; The platelet level is restored quite quickly. At the same time, the leukocyte count gradually increases (sometimes for some period even above normal).

In a number of patients after acute radiation sickness, somatic and genetic consequences . TO somatic consequences include a reduction in life expectancy, the development of cataracts (in 30-40% of cases), and a more frequent development of leukemia and malignant neoplasms. According to the literature, leukemia in those affected by an atomic explosion is observed 5-7 times more often than in those not exposed to radiation. TO genetic consequences include various deformities found in descendants, mental disabilities, congenital diseases, etc.

The severity of the manifestations of the disease and the duration of individual periods are determined by the severity of radiation exposure.

Acute radiation sicknessin some cases it can occur with simultaneous external exposure to radiation and internal radioactive contamination (combined radiation damage).

1. And in these cases, the dose of external radiation will be of decisive importance. However, the clinical picture will additionally reveal signs of damage to the digestive system (gastroenteritis, liver damage).

2. When radioactive substances deposited in bone tissue (strontium, plutonium) are ingested, pathological changes often develop in the bones and may not occur immediately, but after many months and years.

3. The diagnosis of internal radioactive contamination is established using radiometric examination of urine, feces, blood, as well as using external dosimetry, which allows recording the radiation of the affected body after sanitary treatment.

4. Radiometry in the area of the thyroid gland is especially valuable.

More severe forms of ARS (intestinal, toxemic, cerebral) in humans have not been fully studied.

Intestinal form

Irradiation at a dose of 10 to 20 Gy leads to the development of radiation sickness, the clinical picture of which is dominated by signs of enteritis and toxemia caused by radiation damage to the intestinal epithelium, disruption of the barrier function of the intestinal wall for microflora and bacterial toxins.

The primary reaction develops in the first minutes and lasts 3–4 days. Repeated vomiting appears in the first 15 to 30 minutes. Characterized by abdominal pain, chills, fever, and hypotension. Loose stools are often observed on the first day; later, enteritis and dynamic intestinal obstruction are possible. In the first 4–7 days, oropharyngeal syndrome is pronounced in the form of ulcerative stomatitis, necrosis of the oral mucosa and pharynx. From 5–8 days the condition worsens sharply: high body temperature, severe enteritis, dehydration, general intoxication, infectious complications, bleeding. Lethal outcome on days 8–16.

Histological examination of those killed on days 10–16 reveals a complete loss of the intestinal epithelium, due to the cessation of physiological cell regeneration. The main cause of mortality is due to early radiation damage to the small intestine (intestinal syndrome).

Related information.

Acute radiation sickness (ARS) is a simultaneous injury to all organs and systems of the body, but above all - acute damage to the hereditary structures of dividing cells, mainly hematopoietic cells of the bone marrow, lymphatic system, epithelium of the gastrointestinal tract and skin, liver cells, lungs and other organs as a result of exposure to ionizing radiation.

Being a trauma, radiation damage to biological structures is strictly quantitative in nature, i.e. Small impacts may not be noticeable, but large ones may cause fatal injuries. The dose rate of radiation exposure also plays a significant role: the same amount of radiation energy absorbed by a cell causes greater damage to biological structures, the shorter the duration of irradiation. Large doses of exposure extended over time cause significantly less damage than the same doses absorbed over a short period of time.

The main characteristics of radiation damage are thus the following two: the biological and clinical effect is determined by the radiation dose ("dose - effect"), on the one hand, and on the other, this effect is also determined by the dose rate ("dose rate - effect").

Immediately after irradiation of a person, the clinical picture turns out to be poor, sometimes there are no symptoms at all. That is why knowledge of a person’s radiation dose plays a decisive role in the diagnosis and early prognosis of the course of acute radiation sickness, in determining therapeutic tactics before the development of the main symptoms of the disease.

In accordance with the dose of radiation exposure, acute radiation sickness is usually divided into 4 degrees of severity: mild (radiation dose in the range of 1-2 Gy), moderate (2-4 Gy), severe (4-6 Gy) and extremely severe (6 Gy) . When irradiated at a dose of less than 1 Gy, they speak of acute radiation injury without signs of disease, although small changes in the blood in the form of transient moderate leukocytopenia and thrombocytopenia approximately a month and a half after irradiation, some asthenia may occur. In itself, the division of patients according to severity is very arbitrary and pursues specific goals of sorting patients and carrying out specific organizational and therapeutic measures in relation to them.

The system for determining dose loads using biological (clinical and laboratory) indicators in victims exposed to ionizing radiation was called biological dosimetry. In this case, we are not talking about true dosimetry, not about calculating the amount of radiation energy absorbed by tissues, but about the correspondence of certain biological changes to the approximate dose of short-term, simultaneous general irradiation; This method allows you to determine the severity of the disease.

The clinical picture of acute radiation sickness, depending on the radiation dose, varies from almost asymptomatic at doses of about 1 Gy to extremely severe from the first minutes after irradiation at doses of 30-50 Gy or more. At doses of 4-5 Gy of total body irradiation, almost all the symptoms characteristic of acute human radiation sickness will develop, but less or more pronounced, appearing later or earlier at lower or higher doses. Immediately after irradiation, the so-called primary reaction appears. Symptoms of the primary reaction to radiation consist of nausea and vomiting (30-90 minutes after radiation), headache, and weakness. At doses less than 1.5 Gy, these phenomena may be absent; at higher doses they occur and the degree of their severity increases, the higher the dose. Nausea, which may be limited to the primary reaction in mild cases of the disease, is replaced by vomiting; with increasing radiation dose, vomiting becomes repeated. This dependence is somewhat disrupted by the incorporation of radionuclides due to irradiation from a radioactive cloud: vomiting can be repeated and persistent even at a dose close to 2 Gy. Sometimes victims note a metallic taste in the mouth. At doses above 4-6 Gy of external irradiation, transient hypermia of the skin and mucous membranes, swelling of the mucous membrane of the cheeks and tongue with light marks of teeth on it occur. When exposed to radiation from a radioactive cloud. when the skin and mucous membranes are simultaneously exposed to j and b components, during inhalation of radioactive gases and aerosols, early onset of nasopharyngitis, conjunctivitis, and radiation erythema is possible, even with mild acute radiation sickness developing.

Gradually - over several hours - the manifestations of the primary reaction subside: vomiting ends, headache decreases, hyperemia of the skin and mucous membranes disappears. The patients' well-being improves, although severe asthenia and very rapid fatigue remain. If external irradiation was combined with the ingestion of radionuclides, which directly act on the mucous membrane of the respiratory tract and intestines, then in the first days after irradiation there may be loose stools several times a day.

All these phenomena pass in the coming days, but after a certain period of time they arise again as the main and very dangerous signs of acute radiation sickness. At the same time, in addition to the quantitative relationship between the dose and the effect, there is another phenomenon characteristic of radiation injuries between the dose rate and the effect: the higher the dose, the earlier the specific biological effect will occur. This phenomenon lies in the fact that vomiting, specific to the primary reaction, occurs earlier at a high dose; the main signs of the disease are: radiation stomatitis, enteritis, a drop in the number of leukocytes, platelets, reticulocytes with all their patterns, hair removal, skin damage, etc. - appear earlier the higher the dose. The described phenomenon is called the “dose-time effect” relationship; it plays a vital role in biological dosimetry.

In many victims, without strict dependence on the dose, a transient enlargement of the spleen can be noted in the first days of the illness. The breakdown of red bone marrow cells may cause mild icterus of the sclera and an increase in the level of indirect bilirubin in the blood, noticeable on the same days, then disappearing.

Forms of acute radiation sickness

ARS with predominant damage to the blood system

Doses over 100 r cause the bone marrow form of ARS of varying severity, in which the main manifestations and outcome of L. b. depend mainly on the degree of damage to the hematopoietic organs. Doses of single total radiation above 600 r are considered absolutely lethal; Death occurs within 1 to 2 months after irradiation. In the most typical form of acute L. b. initially, after a few minutes or hours, those who received a dose of more than 200 r experience primary reactions (nausea, vomiting, general weakness). After 3-4 days, the symptoms subside, and a period of imaginary well-being begins. However, a thorough clinical examination reveals further development of the disease. This period lasts from 14-15 days to 4-5 weeks. Subsequently, the general condition worsens, weakness increases, hemorrhages appear, and body temperature rises. The number of leukocytes in the peripheral blood, after a short-term increase, progressively decreases, falling (due to damage to the hematopoietic organs) to extremely low numbers (radiation leukopenia), which predisposes to the development of sepsis and hemorrhages. The duration of this period is 2-3 weeks.

ARS with predominant involvement of the gastrointestinal tract (intestinal form)

With general irradiation in doses from 1000 to 5000 r, the intestinal form of L. develops, characterized primarily by intestinal damage leading to disruption of water-salt metabolism (from heavy diarrhea) and circulatory disorders. Manifestations are observed in the form of radiation stomatitis, gastritis, colitis, eosaphagitis, etc. A person with this form usually dies within the first day, bypassing the usual phases of development of L. b.

ARS with predominant damage to the central nervous system (cerebral form)

After general irradiation in doses exceeding 5000 r, death occurs within 1-3 days or even at the moment of irradiation itself from damage to brain tissue (this form of brain injury is called cerebral). This form of the disease is manifested by general cerebral symptoms: workload; rapid exhaustion, then confusion and loss of consciousness. Patients die due to symptoms of cerebral coma in the first hours after irradiation.

ARS in victims of accidents at reactors and nuclear power plants

In case of accidents at experimental reactor installations, when irradiation is determined by the lightning-fast formation of a critical mass, a powerful flow of neutrons and gamma rays, when the irradiation of the victim’s body continues for a fraction of a second and ends on its own, the personnel must immediately leave the reactor hall. Regardless of the well-being of the victims, everyone in the room should be immediately sent to the health center or immediately to the medical unit if it is located several minutes from the accident site. With an extremely severe degree of damage, vomiting may begin within a few minutes after irradiation, and traveling in a car will provoke it. In this regard, if the hospital is not close to the scene of the accident, victims can be transferred there even after the end of the initial reaction, leaving them in the medical unit rooms while they vomit. Victims with severe damage should be placed in separate rooms so that the sight of vomiting in one does not provoke it in another.

After the vomiting stops, all victims should be transported to a specialized clinic.

In case of explosions of nuclear and thermonuclear bombs, accidents at industrial installations with the release of radioactive gases and aerosols, due to the release of unstable isotopes, the actions are somewhat different. First, all personnel must leave the affected area as soon as possible. For a sharp increase in radiation dose, extra seconds of staying in a cloud of aerosols and gases are important. Many isotopes of radioactive gases and aerosols have a half-life of seconds, i.e. they “live” for a very short time. This is precisely what explains the seemingly strange fact of completely different degrees of damage in people who were in an emergency situation almost nearby, but with a small (often imperceptible to them) difference in time. All personnel must know that it is strictly forbidden to pick up any objects located in the emergency room, and they must not sit on anything in this room. Contact with objects heavily contaminated with j-, b-emitters will lead to local radiation burns.

In the event of an accident, all emergency building personnel must immediately put on respirators and take a potassium iodide tablet as soon as possible (or drink three drops of iodine tincture diluted in a glass of water), since radioactive iodine accounts for significant radiation activity.

After leaving the emergency room, victims are thoroughly washed with soap in the shower. All their clothes are confiscated and subjected to radiation monitoring.

They dress the victims in different clothes. The question of the duration of washing and hair cutting is decided according to radiation monitoring data. Everyone is immediately given an addiction bar. The appearance of diarrhea shortly after the accident is associated with taking potassium iodide (it can actually cause diarrhea in some people). However, as a rule, diarrhea in the first days after exposure to a radioactive cloud is caused by radiation damage to the mucous membrane of the gastrointestinal tract.

Treatment of ARS at the stages of evacuation, in peacetime and wartime

Due to the fact that accidents at nuclear power plants and conflicts involving the use of nuclear weapons are characterized by massive sanitary losses, the first place in the organization of emergency management is the triage of those affected.

Initial triage for upcoming hospitalization or outpatient follow-up

1. Irradiation without developing signs of disease (irradiation dose up to 1 Gy) and/or mild acute radiation sickness (ARS) severity (1 - 2 Gy). Patients do not need special treatment, only outpatient observation is necessary. Patients can be left (with the exception of additional exposure) in place or assigned to a local medical facility closest to the accident zone (residence).
2. Moderate acute radiation sickness severity (1 - 2 Gy). Early initiation of specialized treatment guarantees survival.
3. Acute severe radiation sickness severity (4 - 6 Gy). Patients are likely to survive if treated promptly.
4. Extremely severe acute radiation sickness(more than 6 Gy). Survival with treatment is possible in isolated cases. Tactics in relation to this group of patients differ in case of mass lesions and minor incidents.

The division of ARS according to severity, based on dose loads, and not on the nature and severity of the painful manifestations themselves, makes it possible, first of all, to save from hospitalization those affected by a dose of less than 1 Gy. Only persons with severe damage, when the radiation dose exceeds 4 Gy, require immediate hospitalization in a specialized hematology hospital, since in the coming days or weeks after irradiation they develop agranulocytosis, deep thrombocytopenia, necrotic enteropathy, stomatitis, radiation damage to the skin and internal organs . Agranulocytosis also develops in ARS of moderate severity, so such victims also require hospitalization, but in case of mass lesions in exceptional cases it can be postponed for 2 weeks.

First medical and pre-medical aid are described above; in this regard, we will consider the scope of qualified and specialized assistance.

In case of radiation injury of severe and extremely severe degrees, emergency care may be required due to the occurrence of a primary reaction, due to the severity of its manifestations, which are not characteristic of the primary reaction during general irradiation of mild and moderate severity. Such manifestations include, first of all, repeated vomiting that occurs after 15-30 minutes. after irradiation (with prolonged exposure, vomiting may occur later). You should try to interrupt it and alleviate it with intramuscular or intravenous administration of 2 ml (10 mg) of metoclopramide (cerucal, raglan); taking it in tablets when vomiting is pointless. The drug is administered intravenously either dropwise or very slowly (10-30 minutes), which increases its effectiveness. Repeated administration of metoclopramide every 2 hours is possible and advisable in case of recurrent vomiting.

To reduce vomiting, you can administer 0.5 ml of a 0.1% atropine solution subcutaneously or intramuscularly. If vomiting becomes uncontrollable due to developing hypochloremia, it is necessary to administer 30-50 (up to 100) ml of 10% (hypertonic) sodium chloride solution intravenously. After this, you need to prohibit the patient from drinking for several hours. To eliminate dehydration caused by repeated or indomitable vomiting, saline solutions should be administered intravenously: either isotonic sodium chloride solution (500-1000 ml) intravenously or, in extreme cases, subcutaneously, or 500-1000 ml of Trisol solution (5 g sodium chloride, 4 g of sodium bicarbonate and 1 g of potassium chloride per 1 liter of water, it is sometimes conventionally called a 5:4: 1 solution), or 1000 ml of a 5% glucose solution with 1.5 g of potassium chloride and 4 g of sodium bicarbonate.

With fractionated total irradiation at a dose of 10 Gy (for bone marrow transplantation, for example), antipsychotics and sedatives are used to reduce vomiting and nausea that develop even with low-power irradiation. More often, aminazine (chlorpromazine) is used at a dose of 10 mg/m2 (2.5% solution in ampoules of 1.2 or 5 ml, i.e. 25 mg per 1 ml) and phenobarbital (luminal) at a dose of 60 mg/m2 ( powder or tablets of 0.05 and OD g). These drugs are administered repeatedly, chlorpromazine intravenously. However, their use outside the hospital and in case of massive radiation injury, as well as haloperidol (intramuscular 0.4 ml of 0.5% solution) or ydroperidol (1 ml of 0.25% solution), is excluded, since it requires constant monitoring of blood pressure, which even without them use in cases of extremely severe primary reaction to radiation may be reduced. During this period, the liquid is administered every 4 and 1 liter, then (after 24 and this regimen) every 8 hours, alternating the Trisol solution and a 5% glucose solution with potassium chloride and sodium bicarbonate (1.5 and 4 g, respectively, per 1 liter of glucose) .

The administration of fluids reduces toxicity caused by massive cellular breakdown. For the same purpose, it is advisable to use plasmapheresis in case of an extremely severe primary reaction, replacing the removed plasma with saline solutions (see above), 10% albumin solution (100.200 ml to 600 ml).

Cellular breakdown can cause disseminated intravascular coagulation syndrome - thickening of the blood, its rapid coagulation in the needle during vein puncture, or the appearance of hemorrhagic rashes in the subcutaneous tissue, despite the initially normal level of platelets, which does not decrease in the first hours and days of ARS. In this case, it is advisable to inject fresh frozen plasma (60 drops per minute) 600-1000 ml, administer heparin (intravenous drip at the rate of 500-1000 IU/hour or 5000 IU under the skin of the abdominal wall 3 times a day), as well as plasmapheresis.

An extremely severe degree of ARS may be accompanied by the development of collapse or shock, confusion due to cerebral edema. In case of collapse caused by the redistribution of fluid in the tissues and hypovolemia, it is sufficient to forcefully administer fluid, for example, saline solutions or a 5% glucose solution at the rate of 125 ml/min (1-2 l in total), and intramuscular administration of cordiamine (2 ml) for bradycardia 0.5 ml of 0.1% atropine solution is administered. Reopolyglucin can also be used to eliminate hypovolemia; as a disaggregant, it also reduces hypercoagulation. However, in case of cerebral edema, rheopolyglucin should be used with caution, as it can intensify it. For cerebral edema, diuretics are used (40-80 mg of Lasix intravenously or intramuscularly), the drug is administered under blood pressure control. To eliminate cerebral edema, 60-90 mg of prednisolone can be administered intravenously. Hypertonic glucose solution (40%) should be used for this purpose with caution, since by causing hypervolemia, it can increase cerebral edema. If cerebral edema occurs, as with other phenomena of severe intoxication caused by cellular decay, plasmapheresis is advisable.

If the patient develops shock, then anti-shock measures are necessary: intravenous administration of large doses of prednisolone - up to 10 mg/kg hydrocortisone - up to 100 mg/kg, anti-shock fluids under the control of central venous pressure (norm 50-120 mm water column), dopamine (under blood pressure control), 5-10% albumin solution - from 200 to 600 ml. Since any shock is accompanied by DIC syndrome or develops in connection with it, it is simultaneously necessary to use drugs to relieve DIC syndrome (see above).

Emergency care may become necessary during the development of hematological syndrome, its main manifestation is myelotoxic agranulocytasis. During this period, such life-threatening complications as sepsis and septic shock, necrotizing enteropathy and septic shock or bleeding and hemorrhagic shock, DIC syndrome are possible.

In the treatment of sepsis and septic shock, the main thing is to suppress the microflora that caused it. In the first few days, parenteral administration of large doses of highly active broad-spectrum antibiotics (from the group of semisynthetic penicillins or cephalosporins and aminoglycosides) is necessary, then, when the pathogen is identified, targeted drugs: for pneumococcal sepsis - large doses of penicillin; for pseudomonas sepsis - carbenicillin (30 g per day) in combination with aminoglycosides (gentamicin or amikacin 240 mg/day or 300 mg/day, respectively); for staphylococcal sepsis - cefamezine 4-6 g/day; for fungal sepsis - amphoteracin-B (intravenously at the rate of 250 units/kg), nystatin and nasoral orally. At the same time, it is necessary to administer intravenously gamma globulin (endobulin, gammaimmune, sandobulin) in a dose of 1/10 kg once every 7-10 days. In the treatment of sepsis, plasmapheresis is used, which activates phagocytosis (primarily spleen macrophages). The use of fresh frozen plasma and heparin to relieve disseminated intravascular coagulation (DIC) complicating sepsis also makes it possible to cope with local lesions: necrotic enteropathy, tissue necrosis, liver and kidney failure.

Local purulent processes, more often foci of necrosis, since we are talking about lesions in the period of agranulocytosis, can be stopped by applying 4 times a day a 10-20% solution of dimexide with an antibiotic, to which the microflora isolated from the lesion is sensitive, or with a broad-spectrum antibiotic ( in a daily dose).

In the case of the development of necrotizing enteropathy as a complication of agranulocytosis or as an independent process - intestinal syndrome caused by radiation damage to the small intestine, complete fasting is first of all necessary, and you are allowed to drink only boiled water, but not tea or juices, etc. Saline solutions are injected intravenously and it is possible, but not strictly necessary, to administer parenteral nutrition 15DO-2500 kcal/day. To suppress the infection, which is easily complicated by sepsis with necrotic enteropathy in conditions of agranulocytosis, intensive parenteral (only intravenous administration of drugs is allowed in connection with agranulocytosis) antibiotic therapy (see above treatment of sepsis). Along with it, non-absorbable antibiotics are used orally, most often vibramycin, kanamycin or polymyxin, or biseptol (6 tablets per day) and nystatin (6-10 million units / day).

For hemorrhagic syndrome, usually caused by thrombocytopenia, platelet mass is transfused in 4 doses (1 dose, which is sometimes called a unit, is 0.7.1011 cells), for a total of about 3.1011 cells in one procedure, 2 times a week, and more often if necessary. In case of bleeding, a jet (60 drops per minute under central venous pressure control) infusion of 600-1000 ml of fresh frozen plasma, as well as platelet transfusion, is necessary.

Combined radiation injuries. Principles of treatment

Due to the very nature of ARS, the occurrence of which is associated with emergency situations, the use of nuclear weapons, accidents at reactor installations, terrorist attacks - a very different combination of ARS and other pathology complicating its course is possible. Here are some of them:

Traumatic injuries. Fractures. Bruises.
Traumatic brain injury.
Gunshot wounds.
Burns. Temperature and acid-base.
Defeat of SDYAV.
Diseases of internal organs.
Infectious diseases.
Psychiatric pathology.

All these diseases are combined with ARS, both independently and in combination, aggravating its course. However, despite this, the principles of treatment of ARS remain the same, the tactics of treating these diseases have changed somewhat. We should remember that after the end of the primary reaction, patients begin a period of well-being, ending after a few days with the onset of pronounced clinical manifestations. Consequently, all surgical procedures that are traumatic for the patient should be performed immediately after the end of the primary reaction period or during it. When prescribing pharmacological drugs, you should avoid prescribing drugs that inhibit hematopoiesis: NSAIDs, some antibiotics, glucocorticoids, cytostatics, etc.

ACUTE RADIATION DISEASE CLINIC

Parameter name	Meaning
Article topic:	ACUTE RADIATION DISEASE CLINIC
Rubric (thematic category)	Radio

CLASSIFICATION OF ACUTE RADIATION SICKNESS

ACUTE RADIATION SICKNESS

Acute radiation sickness (ARS) is a disease resulting from short-term (from several minutes to 1-3 days) exposure of the entire body or most of it to ionizing radiation (gamma rays, neutrons, X-rays) in a dose exceeding 1 Gy , and characterized by a phased course and polymorphism of clinical manifestations (Table 1). Taking into account the dependence on the dose of external radiation, cerebral, toxemic, gastrointestinal and typical, or bone marrow, forms of acute radiation sickness are distinguished.

The cerebral form of ARS occurs with general irradiation at a dose of more than 80-100 Gy. In this case, direct damage to the central nervous system occurs with profound disruption of its functions. Severe psychomotor agitation, disorientation, and subsequent adynamia, respiratory and circulatory disorders, and convulsions occur. Victims die within the first hours after exposure.

The toxemic form of ARS develops at radiation doses of 50-80 Gy. Due to severe intoxication with tissue metabolic products, those affected also experience severe disturbances in the functional state of the central nervous system. Death occurs within the first 3-8 days after the lesion.

The gastrointestinal form of ARS develops with irradiation at a dose of 10-50 Gy. In victims, severe gastrointestinal disorders predominate - uncontrollable vomiting, diarrhea, tenesmus, paresis of the stomach and intestines. This form of the disease usually ends in death within 5-10 days from the moment of exposure.

The bone marrow (typical) form of ARS occurs at radiation doses of 1-10 Gy and, due to the real prospects for recovery, has the greatest practical importance. The main pathogenetic and clinical changes are pathological changes in the blood system (cytopenia, coagulation disorders), hemorrhagic syndrome, and infectious complications.

Acute radiation exposure in doses less than 1 Gy does not lead to the development of radiation sickness, but manifests itself as a radiation reaction in the 4th – 6th week.

In the pathogenesis of radiation sickness, the following points are important: 1) direct and indirect effects of ionizing radiation on the cells and tissues of the irradiated body with maximum damage to radiosensitive elements (lymphoid, myeloid tissue; germinal, intestinal and integumentary epithelium; secretory cells of the digestive and endocrine glands ); 2) metabolic disorders, formation and circulation in the blood of radiotoxic substances that enhance the biological effect of penetrating radiation; 3) disintegration of the neuroendocrine system, disruption of regulatory influences on internal organs; 4) dysfunction of the vascular system and the development of bleeding; 5) disorders of hematopoiesis and immunogenesis, decreased resistance to injections.

The morphological substrate of acute radiation sickness is: a) dystrophic changes in organs and tissues; b) bone marrow depletion; c) signs of hemorrhagic syndrome; d) infectious complications.

During the clinical course ARS (mainly of the bone marrow form) is distinguished into four periods: the period of the primary reaction, or initial; hidden, or latent; period of height, or pronounced clinical manifestations; recovery period.

Primary reaction period is characterized primarily by neuroregulatory disorders (dyspeptic syndrome), redistribution changes in the composition of the blood (transient neutrophilic leukocytosis), and disorders of the analyzing systems. The direct damaging effect of penetrating radiation on lymphoid tissue and bone marrow reveals itself as lymphopenia, death of young cellular elements, and the presence of chromosomal aberrations in cells of the lymphoid and myeloid type. Typical clinical symptoms of this period based on the severity of ARS are presented in Table 2.

Hidden period characterized by external well-being, subsidence of vasovegetative disorders with a gradual increase in pathological disorders with a gradual increase in pathological changes in the most affected organs (lymphatic system, bone marrow, germinal and intestinal epithelium). The severity of these changes is proportional to the magnitude of the absorbed radiation dose (Table 3).

High period begins with a deterioration in health. Appetite disappears, headaches, nausea and vomiting reappear, general weakness, weakness, body temperature rises. Tachycardia, expansion of the borders of the heart, dullness of heart sounds, and hypotension are noted. The ECG shows a decrease in wave voltage, extrasystoles, a decrease in the S-T segment, and distortion of the T wave. Bronchitis and pneumonia, glossitis, ulcerative necrotizing stomatitis, and gastroenterocolitis are often detected. Hemorrhagic diathesis develops. Severe neurological disorders may be detected. Changes in blood and hematopoiesis progress (Table 4). During bacteriological examination, it is possible to inoculate a variety of flora from the blood of patients (Escherichia coli, staphylococcus, Proteus, yeast fungi, etc.) Signs of general intoxication increase.

Recovery period manifested by improved well-being, normalization of body temperature, renewed appetite, disappearance of signs of hemorrhagic diathesis. Restoration of impaired functions and bone marrow hematopoiesis is often delayed for a long time. Asthenia, lability of blood pressure and hematological parameters (short-term leukocytosis, thrombocytosis), some trophic and metabolic disorders remain for a long time.

CLINIC OF ACUTE RADIATION DISEASE - concept and types. Classification and features of the category "CLINIC OF ACUTE RADIATION DISEASE" 2017, 2018.

Ticket 16.

Acute radiation sickness of mild (I) and moderate (II) severity. Clinic, diagnosis, treatment at the stages of medical evacuation.

Acute radiation sickness develops as a result of the death of dividing cells under the influence of short-term radiation at a dose of more than 1 Gy (100 rad). The development of the disease is possible under conditions of a nuclear power plant accident and after total irradiation of the body for therapeutic purposes. There is a strict dependence of its manifestations on the absorbed dose of ionizing radiation. Radiation energy leads to damage to cellular structures, which causes the development of mainly hematological syndrome.

Clinic for various forms of radiation sickness

In the case of a single irradiation dose of 0.25 Gy, routine clinical examination does not reveal noticeable deviations.

When irradiated at a dose of 0.25-0.75 Gy, mild changes in the blood picture and neurovascular regulation may be noted, occurring in the 5-8th week from the moment of irradiation.

Irradiation at a dose of 1-10 Gy causes typical forms of ARS with a disorder of hematopoiesis leading in its pathogenesis.

Irradiation at a dose of 10-20 Gy leads to the development of the intestinal form with a fatal outcome on the 10-14th day.

When a person is irradiated at a dose of 20-80 Gy, death occurs on the 5-7th day with increasing azotemia (toxemic form).

Direct early damage to the nervous system develops with irradiation at a dose of more than 80 Gy. A fatal outcome in the nervous (acute) form is possible in the very first hours or days after irradiation.

During the bone marrow form there are 4 periods:

I - period of the primary general reaction;

II - period of visible clinical well-being (latent);

III - the period of pronounced clinical manifestations (the height of the disease);

IV - recovery period.

The division of the disease into these periods is relative; it is valid for very uniform exposure.

According to the absorbed doses, acute radiation sickness is usually divided into 4 degrees of severity:

1) light (1-2 Gy);

2) medium (2-4 Gy);

3) severe (4-6 Gy);

4) extremely severe (more than 6 Gy).

The clinical picture of the primary reaction depends on the radiation dose. With a mild degree of the disease, some affected people do not show any signs of a primary reaction at all. But most people experience mild nausea 2-3 hours after irradiation; some may vomit once after 3-5 hours. In the following days, patients feel rapid fatigue during physical activity.

The leading symptom of the primary reaction with moderate severity is vomiting. It occurs 1.5-3 hours after irradiation: the higher the dose and the more irradiated the upper half of the abdomen and chest, the earlier vomiting will occur, and the longer it will last. Along with vomiting, patients note the appearance of general weakness, and at doses of about 4 Gy, moderate redness of the face and slight injection of the sclera are observed. During the day, the symptoms of the primary reaction subside: after 5-6 hours, vomiting stops, weakness gradually disappears. Moderate headache and fatigue persist. Mild facial hyperemia disappears within 2-3 days. A certain place in the characteristics of the primary reaction is occupied by a change in the number of leukocytes in the peripheral blood. In the first hours after irradiation, there is an increase in the number of leukocytes, mainly due to neutrophils. This initial leukocytosis, lasting less than a day, does not show a clear relationship with the dose of exposure, although it may be noted that high leukocytosis is observed more often in more severe cases of injury. The increase in the number of redistributive leukocytes is due to the release of granulocyte reserve from the bone marrow, while the height and duration of leukocytosis do not have a clear dependence on the intensity of irradiation. In this regard, primary leukocytosis is not a reliable indicator of the severity of radiation injury.

The period of external well-being is determined by the dose of radiation exposure and can last from 10-15 days to 4-5 weeks.

In many patients with mild disease severity, at a dose of less than 1.5 Gy, there is no clear clinical picture of the primary reaction, and therefore, in these cases it is difficult to talk about the latent period.

With moderate severity, after the end of the primary reaction, there are insignificant deviations in the well-being of patients: it is difficult for them to do physical labor, it is difficult for them to concentrate for intellectual work, they get tired quickly, although they give the impression of healthy people. Distinct changes are detected in the hematological picture: the number of leukocytes and platelets in the peripheral blood fluctuates. By the 7-9th day, the number of leukocytes decreases to 2000-3000 in 1 μl, then a temporary increase or stabilization of indicators occurs, lasting until 20-32 days, then agranulocytosis occurs, which mainly determines the clinical signs of the height of the disease. The number of platelets and reticulocytes changes similarly.

During the latent period of hematological syndrome, epilation develops, as well as damage to the skin and mucous membranes.

The peak period should be determined primarily by the primary signs of the disease - a decrease in the number of leukocytes and platelets in the peripheral blood. Lymphocytes, due to their very high radiosensitivity, decrease already in the first days after irradiation, but lymphopenia does not noticeably affect the clinical picture of the disease.

With uniform irradiation in medium doses, the period of the height of the disease is characterized exclusively by leuko- and thrombocytopenia and associated complications of an infectious nature, bleeding.

A mild degree at a dose of 1-1.5 Gy is usually not accompanied by agranulocytosis, and therefore there are no infectious complications. The height of the period can only be noted by the decrease in leukocytes to 1500-2000 per 1 μl, which occurs at the beginning or middle of the second month of the disease. Until this period, the abortive rise in the number of leukocytes continues. When the radiation dose approaches 2 Gy, agranulocytosis develops on the 32nd day of the disease, and the clinical picture of the disease corresponds to the average severity of the lesion. The duration of agranulocytosis does not exceed 7-8 days, but it can be very deep (up to 200-500 cells in 1 μl in the complete absence of granulocytes), which causes severe infectious complications. The most common are follicular and lacunar tonsillitis, however, as with any myelotoxic agranulocytosis, the possibility of severe pneumonia, esophagitis, perforated intestinal ulcers, and the development of sepsis cannot be excluded.

If the beginning of the period of the height of the disease should be determined not by external manifestations, but by the fall of leukocytes below critical numbers, then the end of agranulocytosis is sometimes marked not so much by the rise in the number of leukocytes, but by the improvement of the patient’s condition, by the normalization of temperature. Essentially, activation of hematopoiesis occurs earlier, but with a slight increase in granulocytes in the blood, almost all of them are absorbed by the infectious focus.

The picture of the bone marrow during the peak period corresponds to complete aplasia: the trepanate shows the disappearance of foci of hematopoiesis, there are almost no hematopoietic cells. A few days before the cessation of agranulocytosis, before the appearance of granulocytes in the peripheral blood, clear signs of proliferation of hematopoietic cells are already observed in the bone marrow.

When exposed to a dose of more than 3 Gy on the intestinal area, radiation enteritis develops. With irradiation up to 5 Gy, it manifests itself as mild bloating in the 3-4th week after irradiation, non-frequent, pasty stools, and an increase in temperature to febrile levels. The time of appearance of these signs is determined by the dose: the higher it is, the earlier the intestinal syndrome appears. At high doses, severe enteritis develops: diarrhea, flatulence, abdominal pain, bloating, splashing and rumbling, pain in the ileocecal area. Intestinal syndrome may be accompanied by damage to the colon, in particular the rectum, with the appearance of characteristic tenesmus, radiation gastritis, radiation esophagitis. Radiation gastritis and esophagitis develop at the beginning of the second month of the disease, when bone marrow damage is already behind.

Even later, after 3-4 months, radiation hepatitis begins. Its peculiarity is that jaundice occurs without a prodrome, bilirubinemia is low, but the level of transaminases is very high (from 200 to 250 units), and skin itching is pronounced. Over the course of several months, the process goes through many “waves” and gradually subsides. “Waves” consist of increased itching, a slight increase in bilirubin and severe hypertransaminasemia. The prognosis for liver damage appears to be good, although no specific treatment has yet been found (prednisolone clearly worsens the course of radiation hepatitis).

The most radiosensitive skin is the area of the armpits, inguinal folds, elbows, and neck. Radiation dermatitis goes through phases of primary erythema, edema, secondary erythema, development of blisters and ulcers, and epithelization. The prognosis of skin lesions also depends on the damage to the skin vessels of large arterial trunks. Vessels undergo progressive sclerotic changes over many years, and previously healed skin radiation ulcers can cause repeated necrosis over a long period of time. Outside of vascular lesions, secondary erythema ends with pigmentation at the site of the radiation burn, often with thickening of the subcutaneous tissue. In this area, the skin is usually atrophic, vulnerable, and prone to the formation of secondary ulcers. At the sites of the blisters, nodular skin scars form with multiple angioectasia on atrophic skin.

The recovery period begins at the end of the 2-3rd month, when the general condition of the patients gradually improves. But even with the normalization of blood counts and the disappearance of intestinal disorders, severe asthenia remains. Full recovery in patients can take many months and sometimes years. The composition of the blood is normalized in case of mild degree by the end of the second month, in case of moderate degree - by its middle, and in case of severe degree - by the end of the first, beginning of the second month after irradiation. Restoration of the ability to self-care occurs after the elimination of agranulocytosis, oral and intestinal lesions. With a mild degree, patients do not lose the ability to self-care. With moderate severity, when deciding whether to discharge a patient from the hospital, one cannot focus only on the restoration of hematopoiesis. Severe asthenia makes these people unable to work for about six months. Usually, those with a severe degree of illness are discharged from the hospital 4-6 months after the onset of the disease, and sometimes later if the general manifestations of radiation sickness are accompanied by local lesions.

Diagnostics

With a characteristic picture of the primary reaction, knowledge of its temporal characteristics, as well as quantitative and temporal parameters of changes in the levels of lymphocytes, leukocytes, and platelets, the diagnosis of ARS does not present any great difficulties, including the degree of its severity.

Currently, a method of chromosomal analysis of peripheral blood lymphocytes stimulated with phytohemagglutinins has been proposed for the diagnosis of radiation injury. Chromosomal analysis detects overexposure long after exposure, but does not provide reliable information on local doses. The preservation in the bone marrow of cells with damaged chromosomes, capable of mitosis under the influence of phytohemagglutinin many years after irradiation of a given area of the bone marrow, significantly refines biological dosimetry in the long term after irradiation. When the irradiation dose of a given area of the bone marrow is more than 5 Gy, the percentage of cells with chromosomal abnormalities almost equal to 100. Determination of higher doses is possible only in a single cell: the higher the dose, the more the cell is saturated with damaged chromosomes.

Treatment

To prevent vomiting, patients are prescribed Cerucal 1 tablet 5 times a day; the drug can be administered intravenously, 2 ml every 2 hours, 4-6 times a day. If the administration of cerucal does not prevent vomiting, injections of droperidol 0.25% - 1.0 ml or haloperidol 0.5-1.0 ml of a 0.5% solution intramuscularly or subcutaneous injection 0.5-1 can be used .0 ml of 0.1% atropine solution.

Classification of pesticides.

Main groups: